On April 13–14, 2026, GooVentures participated in the Spain-United States Business Summit, held at The Foundry and organized by ICEX in collaboration with Richi Foundation and Oncoheroes Bio.
For GooVentures, this trip to Boston was more than an institutional event.
It was an opportunity to listen, compare perspectives, and reinforce a belief that is deeply embedded in our international strategy:
healthcare innovation needs real bridges between science, technology, capital, and institutions.
And Boston is probably one of the best places in the world to experience that firsthand.
Boston: where innovation happens through proximity
Throughout the summit, one idea repeatedly stood out: Boston is not just a powerful ecosystem because of its well-known institutions and companies.
It is powerful because of its density.
Within just a few miles, you find universities like Harvard University and Massachusetts Institute of Technology, leading hospitals, venture capital firms, pharma companies, startups, research centers, and organizations capable of turning science into global companies.
One speaker described Kendall Square as:
“The most innovative mile on the planet.”
It is not an exaggerated statement. The Boston-Cambridge ecosystem concentrates talent, capital, and scientific knowledge in a way that is difficult to replicate elsewhere. That proximity creates conversations, unexpected encounters, and opportunities that cannot be manufactured through strategy alone.
Several participants referred to these interactions as “constant collisions”: the ongoing intersections between researchers, entrepreneurs, investors, and companies that ultimately lead to the creation of new startups.
For GooVentures, this concept is particularly meaningful.
Our model is also built around connecting worlds that traditionally operate separately:
- Research
- Technology
- Venture building
- Investment
- Clinical validation
- Market access
An event focused on understanding how healthcare innovation is built in Boston
The first day of the summit focused on doing business in Boston and understanding the dynamics of its innovation ecosystem.
Participants included representatives from MassMEDIC, Bain Capital Life Sciences, Flagship Pioneering, and M&T Bank, offering direct perspectives on medtech, life sciences, investment, banking, and institutional innovation.
A few figures help illustrate the scale of the environment:
| Indicator | Key figure |
|---|---|
| Medtech companies in Massachusetts | 500+ |
| Medtech jobs | 40,000+ |
| US medtech market position | 2nd–3rd largest market |
| Bain Capital global AUM | ~$200B |
| Bain Capital Life Sciences minimum ticket | $50M |
| Potential Medicare approval timeline | Up to 5 years |
Beyond the numbers, several ideas strongly resonated with the type of companies GooVentures aims to build.
One message stood out clearly:
in healthcare, technology alone is not enough.
A product must be:
- Clinically validatable
- Fundable
- Adoptable
- Capable of integrating into a complex healthcare system
From MVP to healthcare reality
In many industries, launching quickly is enough to learn.
In digital health, it is not.
A healthtech product must navigate layers that rarely exist in a conventional tech startup:
- Regulation
- Reimbursement
- Clinical validation
- Integration with healthcare workflows
- Institutional trust
- Access to specialized capital
During the summit, speakers repeatedly emphasized an important point: in medtech, the challenge is not always just FDA approval. In many cases, reimbursement pathways—especially within systems such as Medicare—can become equally or even more decisive.
This perspective aligns closely with how GooVentures approaches venture building in healthcare.
It is not about building “health apps.”
It is about building companies prepared to operate inside real healthcare environments.
GooVentures as a bridge between Spain and the United States
One of the strongest takeaways from the summit was that the bridge between Spain and the United States already exists—but it requires organizations capable of strengthening it consistently over time.
This is where GooVentures fits.
Our vision is to operate as an international digital health innovation cluster, connecting:
- Spanish technological talent
- Clinical and scientific research
- Startups with international potential
- Investors
- Institutions
- US healthcare ecosystems
Spain brings creativity, technical capability, and scientifically grounded projects. The United States contributes scale, capital, clinical networks, and a highly mature venture culture.
One of the most powerful quotes from the second day captured this complementarity perfectly:
“Spain is creativity. Boston is scalability.”
The phrase was shared by Ana Maiques, CEO and co-founder of Neuroelectrics, a company present in Kendall Square since 2014 with international distribution across dozens of countries.
For GooVentures, that statement perfectly summarizes the type of connection we aim to strengthen.
What we were looking for in Boston
Our participation in the summit is part of a broader international expansion strategy.
GooVentures is currently expanding its presence in the United States, with Miami as an operational hub and strategic interest in ecosystems such as Boston and San Francisco.
The objective was not simply to attend the event, but to advance several priorities:
- Present the GooVentures model as a healthtech-focused venture studio
- Build relationships with hospitals, research centers, investment funds, and innovation hubs
- Identify collaboration opportunities in digital health and life sciences
- Open conversations for startups within our portfolio
- Strengthen the Spain-US bridge through a long-term strategic approach
Boston is a demanding market.
And precisely because of that, it matters.
Any healthtech company aiming to scale internationally must expose itself to ecosystems where science, investment, and healthcare adoption naturally coexist.
A healthtech portfolio with international ambition
During the event, GooVentures had the opportunity to present its co-creation and investment approach in HealthTech, SportsTech, and WellnessTech startups, with a particular focus on digital health.
Two projects strongly represent this vision.
Blue Route
Blue Route operates in the neurodevelopment space and uses artificial intelligence to support early ASD diagnosis.
Its approach aims to reduce waiting times through:
- Initial digital assessment
- Video analysis
- Personalized therapeutic modules
- Remote professional monitoring
- Progress analytics
It is a strong example of how technology can help democratize access to healthcare solutions, particularly in areas where families often face long and complex processes.
Health Circuit
Health Circuit, linked to Hospital Clínic de Barcelona and IDIBAPS, develops digital health and clinical decision-support solutions.
Its initiatives include:
- Predictive perioperative risk models
- Surgical preparation systems
- Healthcare interoperability
- European clinical innovation projects
GooApps acts as the technical partner, while GooVentures participates as an investor supporting the platform’s evolution.
In both cases, the underlying logic is the same:
transforming knowledge, technology, and validation into scalable healthcare products.
Lessons from the Boston ecosystem
Beyond meetings and networking, the summit left several strategic lessons for GooVentures.
Trust matters as much as the pitch
In Boston, relationships matter.
Access to opportunities depends not only on presentations, but on long-term presence, reputation, and the ability to contribute value consistently.
Healthcare innovation is global
One idea repeatedly shared during the summit was that meaningful innovation can emerge anywhere if it addresses a real medical need.
This reinforces the opportunity for internationally ambitious projects born in Spain.
Capital looks for structure
Specialized funds are not evaluating technology alone.
They look for:
- Teams
- Validation
- Regulatory clarity
- Execution capability
- Market opportunity
Ecosystems are built through density
Boston works because its actors are physically close, connected, and collaborative.
That density cannot be improvised—but it can be connected to externally through the right strategy.
Why this experience matters for GooVentures
Participating in the summit confirmed that GooVentures is moving in the right direction.
Our model does not aim to compete as a traditional technology agency or as a conventional investment fund.
We aim to occupy a more specific space:
co-creating digital health startups through technology, investment, strategy, and international connectivity.
Boston helped validate three ideas:
- The US market values specialization
- Digital health requires structure, not just speed
- The Spain-US bridge has significant potential when built through real relationships
What comes next
This event is not an endpoint.
It is one step within a broader strategy.
GooVentures will continue working to strengthen its international presence, deepen relationships in the United States, and create opportunities for startups capable of generating meaningful healthcare impact.
Our experience in Boston left us with one clear conclusion:
healthcare innovation does not scale through technology alone.
It scales through:
- Ecosystem
- Trust
- Capital
- Validation
- Long-term vision
And that is exactly the kind of bridge GooVentures intends to keep building.
